Paediatric Respiratory Reviews
Volume 7, Issue 1 , Pages 36-44 , March 2006

Secondary pulmonary hypertension

References 

  1. Hislop AA. Developmental biology of the pulmonary circulation. Paediatr Respir Rev. 2005;6:35–43
  2. Rosenzwig EB, Widlitz AC, Barst RJ. Pulmonary arterial hypertension in children. Pediatr Pulmonol. 2004;38:2–22
  3. Widlitz AC, Barst RJ. Pulmonary arterial hypertension in children. Eur Respir J. 2003;21:155–176
  4. Haworth SG. Primary and secondary pulmonary hypertension in childhood: a clinicopathological reappraisal. Curr Top Pathol. 1983;73:91–152
  5. Rutishauser M, Amacher A. Pulmonary hypertension from the viewpoint of the pediatric pulmonologist. Wien Klin Wochenschr. 1986;98:728–732
  6. Fishman AP. Hypoxia on the pulmonary circulation: how and where it acts. Circ Res. 1976;38:221
  7. Mikhail G, Chester AH, Gibbs SR, Borland JA, Banner NR, Yacoub MH. Role of vasoactive mediators in primary and secondary pulmonary hypertension. Am J Cardiol. 1998;82:254–255
  8. Higenbottam T, Cremona G. Acute and chronic hypoxic pulmonary hypertension. Eur Respir J. 1993;6:1207–1212
  9. Ginid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214–221
  10. Christman BW, Mcpherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992;327:70–75
  11. Haworth SG. Pulmonary hypertension in childhood. Eur Respir J. 1993;6:1037–1043
  12. Hirose S, Hosoda Y, Furuya S, Otsuki T, Ikeda E. Expression of vascular endothelial growth factor correlates closely with formation of the plexiform lesion in human pulmonary hypertension. Pathol Int. 2000;50:472–479
  13. Heath D. Remodeling of the pulmonary vasculature in hypoxic lung disease. In:  Peacock AJ editors. Pulmonary Circulation. A Handbook for Clinicians. 1:London: Chapman & Hall Medical; 1996;p. 171–179
  14. Chronic cor pulmonale: report of an expert committee. Circulation 1963; 27: 594–615.
  15. Noonan JA. Cor pulmonale. In:  Chernick V,  Boat TF,  Kendig EL editor. Kendig's Disorders of the Respiratory Tract in Children. Philadelphia: WB Saunders; 1997;p. 826–837
  16. Royce SW. Cor pulmonale in infancy and early childhood. Report on 34 patients with special reference to the occurrence of pulmonary heart disease in CF of the pancreas. Pediatrics. 1951;8:255–274
  17. Ionescu AA, Payne N, Obieta-Fresnedo I, Fraser AG, Shale DJ. Subclinical right ventricular dysfunction in cystic fibrosis. A study using tissue Doppler echocardiography. Am J Respir Crit Care Med. 2001;163:1212–1218
  18. Stern RC, Borkat G, Hirschfeld SS, et al. Heart failure in cystic fibrosis: treatment and prognosis of cor pulmonale with failure of the right side of the heart. Am J Dis Child. 1980;134:267–272
  19. Gotz MH, Burghuber OC, Salzer-Muhar U, Wolosczcuk W, Weissel M, Harter E. Cor pulmonale in cystic fibrosis. J R Soc Med. 1989;82:26–31
  20. Rosenthal A, Tucker CR, Williams RG, Khaw KT, Strieder D, Shwachman H. Echocardiographic assessment of cor pulmonale in cystic fibrosis. Pediatr Clin North Am. 1976;23:327–344
  21. Burghuber OC, Hartter E, Weissel M, Wolosczcuk W, Gotz M. Raised circulating plasma levels of atrial natriuretic peptide in adolescent and adult patients with cystic fibrosis and pulmonary artery hypertension. Lung. 1991;169:291–300
  22. Bright-Thomas RJ, Webb AK. The heart in cystic fibrosis. J R Soc Med. 2002;95:2–10
  23. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients by pulsed Doppler technique. Circulation. 1983;70:657–662
  24. Panidis IP, Ren JF, Holsclaw DS, Kotler MN, Mintz GS, Ross J. Cardiac function in patients with cystic fibrosis: evaluation by two-dimensional and Doppler echocardiography. J Am Coll Cardiol. 1985;6:701–706
  25. Lester LA, Egge AC, Hubbard VS, Camerini-Otero C, Fink RJ. Echocardiography in cystic fibrosis: a proposed scoring system. J Pediatr. 1980;97:742–748
  26. Raeside DA, Smith A, Brown A, et al. Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension. Eur Respir J. 2000;16:282–287
  27. Frazer KL, Tullis DE, Sasson Z, Hyland RH, Thornley KS, Hanly PJ. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest. 1999;115:1321–1328
  28. Fauroux B, Hart N, Belfar S, et al. Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol. 2004;42:5537–5541
  29. Zinman R, Corey M, Coates AL, et al. Nocturnal home oxygen in the treatment of hypoxemic cystic fibrosis patients. J Pediatr. 1989;114:368–377
  30. Davison A, Boossuyt A, Dab I. Acute effects of oxygen, nifedipine, and diltiazenin patients with cystic fibrosis and mild pulmonary hypertension. Pediatr Pulmonol. 1989;6:53–59
  31. Yankaskas JR, Mallory GB. Lung transplantation in cystic fibrosis: consensus conference statement. Chest. 1998;113:217–226
  32. Fan LL, Deterding RR, Langston C. Pediatric interstitial lung disease revisited. Pediatr Pulmonol. 2004;38:369–378
  33. Clement A, et al. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J. 2004;24:686–697
  34. Bush A. Paediatric interstitial lung disease: not just kid's stuff. Eur Respir J. 2004;24:521–523
  35. Fan LL, Mullen ALW, Brugman SM, Inscore SC, Parks DP, White CW. Clinical spectrum of chronic interstitial lung disease in children. J Pediatr. 1992;21:867–872
  36. Brouillette RT, Fernbach SK, Hunt CE. Obstructive sleep apnea in infants and children. J Pediatr. 1982;100:31–40
  37. Nixon GM, Brouillette RT. Sleep-8. Paediatric obstructive sleep apnoea. Thorax. 2005;60:511–516
  38. Blum RH, McGowan FX. Chronic upper airway obstruction and cardiac dysfunction:anatomy, pathophysiology and anaesthetic implications. Paediatr Anaesth. 2004;14:75–83
  39. Ramakrishna S, Ingle VS, Patel VS, Bhat P, Shah FA. Reversible cardio-pulmonary changes due to adeno-tonsillar hypertrophy. Int J Pediatr Otorhinolaryngol. 2000;55:203–206
  40. Barois A. Respiratory problems in severe scoliosis. Bull Acad Natl Med. 1999;183:721–730
  41. Gonzalez C, Ferris G, Diaz J, Fontana I, Nunez I, Marin J. Kyphoscoliotic ventilatory insufficiency: effects of long-term intermittent positive-pressure ventilation. Chest. 2003;124:857–862
  42. White J, Bullock RE, Hudgson P, Gibson GJ. Neuromuscular disease, respiratory failure and cor pulmonale. Postgrad Med J. 1992;68:820–823
  43. Hill NS. Ventilator management for neuromuscular disease. Semin Respir Crit Care Med. 2002;23:293–305
  44. Niermeyer S, Shaffer E, Thilo E, Corbin C, Moore LG. Arterial oxygenation and pulmonary arterial pressure in healthy neonates and infants at high altitude. J Pediatr. 1993;123:768–772
  45. Maggiorini M, Leon-Velarde F. High altitude pulmonary hypertension: a pathophysiological entity to different diseases. Eur Respir J. 2003;22:1019–1025
  46. De-Cleva R, Herman P, Pugliese V, et al. Prevalence of pulmonary hypertension in patients with hepatosplenic mansonic schistosomiasis-prospective study. Hepatogastroenterology. 2003;50:2028–2030
  47. Davidson A, Bossuyt A, Dab I. Acute effects of oxygen, nifedipine, and diltiazen in patients with cystic fibrosis and mild pulmonary hypertension. Pediatr Pulmonol. 1989;6:197–201
  48. Michael JR, Kennedy TP, Fitzpatrick S, Rosenstein BJ. Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with cystic fibrosis and cor pulmonale. Am Rev Respir Dis. 1984;130:516–519
  49. Pepke-Zaba J, Higenbottam T, Dinh-Xuan AT. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 1991;338:1173–1174

PII: S1526-0542(05)00115-6

doi: 10.1016/j.prrv.2005.11.004

Paediatric Respiratory Reviews
Volume 7, Issue 1 , Pages 36-44 , March 2006

Article Tools

* Image Usage & Resolution